KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)

0.5078
Delayed Data
As of 12:00pm ET
 -0.0234 / -4.41%
Today’s Change
0.36
Today|||52-Week Range
2.45
-70.65%
Year-to-Date
No recent news for KaloBios Pharmaceuticals Inc.

Today’s Trading

Previous close0.53
Today’s open0.53
Day’s range0.50 - 0.53
Volume370,319
Average volume (3 months)1,296,659
Market cap$17.5M
Dividend yield--
Data as of 12:00pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)+33.53%
Earnings growth (this year)-7.83%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book0.71

Competitors

 Today’s
change
Today’s
% change
RTGNRuthigen Inc+0.10+2.71%
CPHIChina Pharma Holding...+0.01+1.58%
ABIOARCA Biopharma Inc-0.01-0.90%
DARADARA BioSciences Inc+0.02+2.47%
Data as of 11:58am ET, 04/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$0.00
Annual profit (last year)-$38.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive &
Financial Officer
Herbert C. Cross
CSO, Executive VP-Research &
Development
Geoffrey Thomas Yarranton
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers